Telehealth exercise training in peripheral arterial disease

  • Research type

    Research Study

  • Full title

    A multimodal tele-health behavioural intervention in patients with peripheral arterial disease from low socio-economic areas: a feasibility and pilot randomized controlled trial with embedded process evaluation

  • IRAS ID

    286735

  • Contact name

    James Prentis

  • Contact email

    james.prentis@nhs.net

  • Sponsor organisation

    Newcastle upon Tyne NHS Trust

  • Duration of Study in the UK

    1 years, 0 months, 0 days

  • Research summary

    Peripheral arterial disease is a common, under treated and under researched issue. The vast majority of these patients often have multiple issues which can be improved with targeted behavioural change interventions. NICE have recommended that supervised exercise is the main stay of treatment for intermittent claudication (ischaemic muscle pain on walking due to blocked and narrowed arteries). However, in the vast majority of UK hospitals this isn't undertaken and with the issues around group based sessions and repeated visits to hospital this treatment option is not available with the coronavirus pandemic.

    We proposed a single centre randomised control trial in 60 patients with peripheral arterial disease attending the Freeman Hospital. Patients will be randomised to either an enhanced behavioural change intervention targeting multiple health behaviours vs a simple walking intervention. We will also be embedding focus groups to understand patients experience of thet intervention and whether the intervention is feasible and acceptable allowing changes to be made to the program.

    The primary outcome will be to assess the feasibility and acceptability of the program. We will also be assessing multiple secondary outcomes including functional capacity, quality of life, sleep quality and smoking and alcohol reduction.

  • REC name

    London - Bromley Research Ethics Committee

  • REC reference

    21/LO/0186

  • Date of REC Opinion

    21 Apr 2021

  • REC opinion

    Further Information Favourable Opinion